DE3763856D1 - Markiertes hydantoin-conjugat und seine verwendung in einem analytischen element und in immuntests. - Google Patents

Markiertes hydantoin-conjugat und seine verwendung in einem analytischen element und in immuntests.

Info

Publication number
DE3763856D1
DE3763856D1 DE8787300249T DE3763856T DE3763856D1 DE 3763856 D1 DE3763856 D1 DE 3763856D1 DE 8787300249 T DE8787300249 T DE 8787300249T DE 3763856 T DE3763856 T DE 3763856T DE 3763856 D1 DE3763856 D1 DE 3763856D1
Authority
DE
Germany
Prior art keywords
marked
analytical element
immunity tests
hydantoin
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787300249T
Other languages
English (en)
Inventor
Susan Jean Danielson
Michael William Sundberg
Robert James Olyslager
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Clinical Diagnostics Inc
Original Assignee
Eastman Kodak Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastman Kodak Co filed Critical Eastman Kodak Co
Application granted granted Critical
Publication of DE3763856D1 publication Critical patent/DE3763856D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/535Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9473Anticonvulsants, e.g. phenobarbitol, phenytoin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/805Test papers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/97Test strip or test slide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds
    • Y10S436/816Alkaloids, amphetamines, and barbiturates

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE8787300249T 1986-01-13 1987-01-13 Markiertes hydantoin-conjugat und seine verwendung in einem analytischen element und in immuntests. Expired - Fee Related DE3763856D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/818,303 US4752568A (en) 1986-01-13 1986-01-13 Labeled hydantoin conjugate and its use in analytical element and immunoassays

Publications (1)

Publication Number Publication Date
DE3763856D1 true DE3763856D1 (de) 1990-08-30

Family

ID=25225197

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787300249T Expired - Fee Related DE3763856D1 (de) 1986-01-13 1987-01-13 Markiertes hydantoin-conjugat und seine verwendung in einem analytischen element und in immuntests.

Country Status (5)

Country Link
US (1) US4752568A (de)
EP (1) EP0233690B1 (de)
JP (1) JPS62165151A (de)
CA (1) CA1262526A (de)
DE (1) DE3763856D1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3031973B2 (ja) * 1990-08-16 2000-04-10 富士レビオ株式会社 フェニトイン誘導体
DE69232001T2 (de) * 1991-06-07 2002-06-06 Johnson & Johnson Clinical Diagnostics, Inc. Markierte Hapten-Analoge zur Verwendung in Immunoassays
CA2062240A1 (en) * 1991-06-07 1992-12-08 Susan J. Danielson Labeled hydantoin derivatives for immunoassays
US5284948A (en) * 1991-06-07 1994-02-08 Eastman Kodak Company Drug hapten analogues for immunoassays
EP0517327B1 (de) * 1991-06-07 2001-08-16 Johnson & Johnson Clinical Diagnostics, Inc. Immunoassays unter Verwendung von markierten Hapten-Analogen
DE19502375C2 (de) * 1995-01-26 2000-06-21 Denzel Klaus Betäubungsmittel-Detektionssystem
EP1159612B1 (de) * 1999-03-08 2006-12-13 Lifescan, Inc. Integriertes assay für organfunktion, drogen und/oder metaboliten
US20040018628A1 (en) * 2001-08-31 2004-01-29 Burd John F. Integrated assay for organ function, drug and / or one or more metabolites
CN110054620B (zh) * 2019-04-19 2021-01-26 北京九强生物技术股份有限公司 一种苯巴比妥衍生物及其在免疫检测中的用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4203802A (en) * 1971-05-14 1980-05-20 Syva Company Inhibitable enzyme amplification assay
US3995021A (en) * 1972-05-15 1976-11-30 Biological Developments, Inc. Antigens of 5,5'alkylphenyl barbituric acids and related hydantoin compounds
US3875011A (en) * 1972-11-06 1975-04-01 Syva Co Enzyme immunoassays with glucose-6-phosphate dehydrogenase
US3966556A (en) * 1972-11-06 1976-06-29 Syva Company Compounds for enzyme amplification assay methadone analogs
US4092479A (en) * 1976-04-05 1978-05-30 Baxter Travenol Laboratories, Inc. Labeled 5,5-diphenylhydantoin derivatives for radioimmunoassay
US4160818A (en) * 1976-04-15 1979-07-10 Technicon Instruments Corporation Fluorimetric immunoassay for diphenylhydantoin
IL49685A (en) * 1976-05-31 1978-10-31 Technion Res & Dev Foundation Specific binding assay method for determining the concentration of materials and reagent means therefor
US4182856A (en) * 1978-04-25 1980-01-08 Miles Laboratories, Inc. Reagents for use in binding assays to determine diphenylhydantoin
JPS55111798A (en) * 1979-02-22 1980-08-28 Yukio Kuroiwa Enzyme-labelled compound for determination of oxobarbituric acid derivative and method of determination thereof
US4255566A (en) * 1980-02-19 1981-03-10 Miles Laboratories Flavin adenine dinucleotide derivatives and labeled conjugates prepared therefrom
US4404366A (en) * 1980-05-06 1983-09-13 Miles Laboratories, Inc. Beta-galactosyl-umbelliferone-labeled hapten conjugates
DE3150878A1 (de) * 1981-12-22 1983-06-30 Boehringer Mannheim Gmbh, 6800 Mannheim "verfahren und reagenz zur bestimmung von creatinin"
US4670381A (en) * 1985-07-19 1987-06-02 Eastman Kodak Company Heterogeneous immunoassay utilizing horizontal separation in an analytical element

Also Published As

Publication number Publication date
JPS62165151A (ja) 1987-07-21
JPH0535989B2 (de) 1993-05-27
EP0233690B1 (de) 1990-07-25
CA1262526A (en) 1989-10-31
EP0233690A1 (de) 1987-08-26
US4752568A (en) 1988-06-21

Similar Documents

Publication Publication Date Title
DE3789013D1 (de) Zusammengesetzter analysator-tester.
DE68903532D1 (de) Wetterbestaendigkeitspruefung.
DE59004453D1 (de) Farbstoffmischung und deren Verwendung.
DE68909568D1 (de) Analytisches testgeraet.
KR880701880A (ko) 입자의 저항 및 리액턴스 측정용 입자분석기
DE3580752D1 (de) Groessenvariables intrauterinpessar und empfaengnisverhuetende vorrichtung.
DE3788148D1 (de) Monoklonale Antikörper und deren Verwendung.
BR8500370A (pt) Alma ajustavel e aparelho presador
DE3674632D1 (de) Automatische gebuehrensammelvorrichtung und muenzbehaelter dafuer.
DE3763856D1 (de) Markiertes hydantoin-conjugat und seine verwendung in einem analytischen element und in immuntests.
DE3481137D1 (de) Kombinatorisches waegeresfahren und vorrichtung.
DE69006648D1 (de) Messvorrichtung und -verfahren.
DE3689948D1 (de) Monoklonale antikörper und testverfahren.
DE3778085D1 (de) Bindungstest und testreagens.
DE3766441D1 (de) Anilinotriazine und deren verwendung.
DE3576569D1 (de) Analytisches element und seine verwendung zur bestimmung von haemoglobin in vollblut.
PT82022B (de) Pulverfoermiges bitumenkonzentrat und seine verwendung
DE3786511D1 (de) Immobilisiertes enzympraeparat und seine verwendung.
DE59005524D1 (de) Widerstandsmasse und ihre Verwendung.
DE3868608D1 (de) Organozinn-alkoxycarbonylphenylmercaptide und deren verwendung.
IT8912472A0 (it) Reagente per analisi dei trigliceridi ed analisi che utilizzano lo stesso
KR910001193U (ko) 와 전류계
UA25906A1 (uk) Сортувальhий пристрій
DK0398865T3 (da) Samle- og sorteringsindretning
DE59007243D1 (de) Farbstoffmischungen und deren Verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC., ROCH

8328 Change in the person/name/address of the agent

Free format text: STREHL, SCHUEBEL-HOPF, GROENING & PARTNER, 80538 MUENCHEN

8339 Ceased/non-payment of the annual fee